Details for Patent: 8,420,656

Which drugs does patent 8,420,656 protect, and when does it expire?

Patent 8,420,656 protects VERQUVO and is included in one NDA.

This patent has eighty-seven patent family members in forty-six countries.

Summary for Patent: 8,420,656

Title:	Substituted 5-fluoro-1H-pyrazolopyridines and their use
Abstract:	The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
Inventor(s):	Follmann; Markus (Wulfrath, DE), Stasch; Johannes-Peter (Solingen, DE), Redlich; Gorden (Bochum, DE), Ackerstaff; Jens (Dusseldorf, DE), Griebenow; Nils (Dormagen, DE), Kroh; Walter (Wuppertal, DE), Knorr; Andreas (Erkrath, DE), Becker; Eva-Maria (Wuppertal, DE), Wunder; Frank (Wuppertal, DE), Li; Volkhart Min-Jian (Velbert, DE), Hartmann; Elke (Wuppertal, DE), Mittendorf; Joachim (Wuppertal, DE), Schlemmer; Karl-Heinz (Wuppertal, DE), Jautelat; Rolf (Haan, DE), Bierer; Donald (Haan, DE)
Assignee:	Bayer Intellectual Property GmbH (Monheim, DE)
Application Number:	13/111,856
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Process;

Drugs Protected by US Patent 8,420,656

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Merck Sharp Dohme	VERQUVO	vericiguat	TABLET;ORAL	214377-001	Jan 19, 2021		RX	Yes	No			Y	Y
Merck Sharp Dohme	VERQUVO	vericiguat	TABLET;ORAL	214377-002	Jan 19, 2021		RX	Yes	No			Y	Y
Merck Sharp Dohme	VERQUVO	vericiguat	TABLET;ORAL	214377-003	Jan 19, 2021		RX	Yes	Yes			Y	Y

Foreign Priority and PCT Information for Patent: 8,420,656

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	10 2010 021637	May 26, 2010

International Family Members for US Patent 8,420,656

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2576547		PA2021518	Lithuania
European Patent Office	2576547		CA 2021 00032	Denmark
European Patent Office	2576547		LUC00221	Luxembourg